PRODUCT DETAIL

CONVERIDE 300 mg/25 mg

Code

0355B

MA number

58/0191/14-S

Product Form:

tbl flm 90x300 mg/25 mg (blis.PVC/PVDCAl-nepriehľ.)

MA Status:

D - Marketing Authorisation valid for an unlimited period

Type of procedure:

Decentralised

Therapeutic Class:

58 - HYPOTENSIVA

ATC:

C	CARDIOVASCULAR SYSTEM
C09	AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C09D	ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
C09DA	Angiotensin II antagonists and diuretics
C09DA04	Irbesartan and diuretics

Shelf life:

Route of admin.:

Oral use

Prescription Status:	Medicinal product subject to medical prescription.
Legal basis:	Article 10(1) generic application
MA issued:	04.06.2014
PIL:	PIL_CONVERIDE_05/2022.pdf
SPC:	SPC_CONVERIDE_05/2022.pdf
Safety feature	Yes
Data update:	13.12.2019